FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2022-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2022-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2022-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-1 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-1 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-1 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-2 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-1 | valid | 2026-10-15 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-1 | valid | 2026-10-15 |